Latest Articles
Experts warn: Common perfumes and room fresheners could harm fertility, offer safer alternatives - The New Indian Express
Experts warn: Common perfumes and room fresheners could harm fertility, offer safer alternatives The New Indian Express
Published: Jan. 22, 2025, 2:54 a.m.
Lab firm BioGrad hopes women's health centre could find treatments for 'neglected' conditions like endometriosis and PCOS - MSN
Lab firm BioGrad hopes women's health centre could find treatments for 'neglected' conditions like endometriosis and PCOS MSN
Published: Jan. 22, 2025, 2:20 a.m.
BioGrad opens Europe’s first private research tissue bank as part of a £25m investment into women’s health - Growth Platform
BioGrad opens Europe’s first private research tissue bank as part of a £25m investment into women’s health Growth Platform
Published: Jan. 21, 2025, 2:16 p.m.
EU approves endometrial, lung cancer drugs from GSK and J&J - pharmaphorum
EU approves endometrial, lung cancer drugs from GSK and J&J pharmaphorum
Published: Jan. 21, 2025, 1:59 p.m.
EC approves GSK’s Jemperli-chemo combo for endometrial cancer - Pharmaceutical Technology
EC approves GSK’s Jemperli-chemo combo for endometrial cancer Pharmaceutical Technology
Published: Jan. 21, 2025, 9:35 a.m.
European Commission expands Jemperli plus chemotherapy approval for endometrial cancer - Indian Pharma Post
European Commission expands Jemperli plus chemotherapy approval for endometrial cancer Indian Pharma Post
Published: Jan. 21, 2025, 4:36 a.m.
Potential biomarkers and immune infiltration linking endometriosis with recurrent pregnancy loss based on bioinformatics and machine learning - Frontiers
Potential biomarkers and immune infiltration linking endometriosis with recurrent pregnancy loss based on bioinformatics and machine learning Frontiers
Published: Jan. 21, 2025, 4:35 a.m.
Orexo converts vipoglanstat royalties into Gesynta stake - The Pharma Letter
Orexo converts vipoglanstat royalties into Gesynta stake The Pharma Letter
Published: Jan. 20, 2025, 4:47 p.m.
Lab tech firm BioGrad opening £25m women's health centre - Business Live
Lab tech firm BioGrad opening £25m women's health centre Business Live
Published: Jan. 20, 2025, 2 p.m.
Gesynta Pharma Raises $29M to Advance Non-Hormonal Endometriosis Treatment - Femtech Insider
Gesynta Pharma Raises $29M to Advance Non-Hormonal Endometriosis Treatment Femtech Insider
Published: Jan. 20, 2025, 10:56 a.m.
Link copied to clipboard!